Randomized Clinical Trial of Intensive Computer-based Cognitive Remediation in Recent-onset Schizophrenia
Launched by UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · Jun 10, 2008
Trial Information
Current as of April 24, 2025
Completed
Keywords
ClinConnect Summary
Participation in this study will last approximately 12 months and will involve individuals with recent-onset schizophrenia. All participants will undergo baseline assessments that will include an interview, written tests, blood draws, and electroencephalogram (EEG) and magnetic resonance imaging (MRI) scans. Participants will then be assigned randomly to receive treatment with either computerized neuroadaptive cognitive training or commercially available computer games. Participants will be asked to complete 60-minute sessions of their assigned treatments 5 days per week for 8 weeks. For pa...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical diagnosis of schizophrenia, schizophreniform, or schizoaffective disorder
- • First psychotic episode within the last 3 years
- • Good general physical health
- • Age between 12-35
- • Is fluent and proficient in the English language
- • Achieved clinical stability (e.g., outpatient status for at least 3 months before study entry; on stable doses of medication for at least 1 month before study entry
- • Minors must have parental/legal guardian consent to participate
- Exclusion Criteria:
- • Any neurological disorder
- • History of psychoactive substance abuse in the past 6 months
Trial Officials
Sophia Vinogradov, MD
Principal Investigator
University of California, San Francisco; San Francisco VA Medical Center; NCIRE - The Veterans Health Research Institute
Rachel Loewy, PhD
Study Director
University of California, San Francisco
Cameron Carter, MD
Study Director
University of California, Davis
About University Of California, San Francisco
The University of California, San Francisco (UCSF) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on translating scientific discoveries into effective therapies, UCSF collaborates with a diverse array of stakeholders, including healthcare professionals, industry partners, and patient communities. The university's research programs emphasize interdisciplinary approaches and leverage cutting-edge technology to address complex medical challenges. As a sponsor of clinical trials, UCSF is dedicated to maintaining the highest standards of ethical conduct and scientific rigor, ensuring the safety and well-being of participants while contributing to the broader medical knowledge base.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
San Francisco, California, United States
Sacramento, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials